מכפיל P/S עתידי: Profound Medical Corp (PROF)

Profound Medical Corp. (PROF) is scaling the deployment of TULSA-PRO systems by expanding insurance coverage in the US. This chart from the GURU.Markets terminal illustrates market expectations via the projected P/S metric, while 11.60 represents the current level of the metric. Growth is driven by MRI-therapy patents and recurring sales of consumables, which will facilitate global market share capture through B2B supplies to urological centers.

Profound Medical Corp. maintains its leadership in non-invasive prostate cancer therapy due to the high level of trust urologists place in its MRI systems. GURU.Markets analysts utilize the forward P/S multiple to assess the ratio of market value to projected revenue, accounting for tax incentives, which allows them to determine the business's margin of safety and the risk of overpaying for the issuer's innovative potential.